![[logo] HealthTree Foundation](https://static.healthtree.org/icons/icon_spinner.svg){kind=icon}
![[logo] HealthTree Foundation](https://static.healthtree.org/logo_icon_only.svg){kind=icon}
World Lymphoma Day: News You May Have Missed
On September 15, 2025, World Lymphoma Awareness Day brings attention to the needs of people living with lymphoma as part of September’s Blood Cancer Awareness Month.
Below, discover a roundup of recent lymphoma topics shared on HealthTree News, including managing lymphedema after radiation, updates that may improve access to CAR T-cell therapy, how clinical trials work, and coping with life after treatment.
What is lymphoma?
Lymphoma is a blood cancer that affects a type of white blood cell called lymphocytes. Lymphocytes help fight infection and are located in the lymphatic system, which contains lymph nodes, the spleen, thymus, tonsils, and bone marrow.
There are two main types of lymphoma: non-Hodgkin and Hodgkin. Within these two groups, there are more than 90 different subtypes. A lymphoma specialist can identify the exact subtype and recommend the most appropriate treatment plan for you or your loved one.
Non-Hodgkin lymphoma can happen at any age. Although the majority of people affected are age 65 or older, it is one of the more common cancers among youth. Hodgkin lymphoma is more likely to affect people ages 20 to 39 or those 65 and older. According to the American Cancer Society, about 89,070 people in the United States will be diagnosed with lymphoma in 2025 (80,350 non-Hodgkin and 8,720 Hodgkin).
HealthTree News regularly shares updates about lymphoma to help people and their care partners stay informed. Here are some of the highlights you may have missed:
Lymphedema after radiation for lymphoma: Signs, risk factors, and treatment
Lymphedema can develop after radiation therapy for lymphoma. This condition happens when lymph fluid builds up under the skin, causing swelling in areas such as the arms or legs. It can occur shortly after treatment or even years later, which makes long-term awareness important. Recognizing early signs like heaviness, tightness, or skin changes and communicating them to your doctor may help prevent it from getting worse.
Managing lymphedema includes complete decongestive therapy with a certified lymphedema therapist. They can help you with gentle manual lymphatic drainage, compression wraps or garments, specific exercises, and careful skin care. Continue reading here.
FDA determines CAR-T can be safely given without risk evaluation and mitigation strategies (REMS)
On June 27, 2025, the U.S. Food and Drug Administration (FDA) removed special safety requirements, called Risk Evaluation and Mitigation Strategies (REMS), from currently approved autologous CAR T-cell therapies. For people with lymphoma, this change applies to the CAR-T products axi-cel (Yescarta), brexu-cel (Tecartus), liso-cel (Breyanzi), and tisa-cel (Kymriah).
This means hospitals and treatment centers no longer need special certification or to keep the medicine tocilizumab immediately available on-site. Some monitoring requirements were also reduced. For example, patients now only need to stay near a treatment center and avoid driving for two weeks after infusion, instead of longer periods. These updates may make CAR-T easier to access. Learn more about this topic here.
What people with lymphoma should know about clinical trials
Clinical trials are research studies that test new therapies and compare them with current standard care. Most lymphoma trials do not use placebos alone. Patients usually receive either the standard treatment or the standard treatment plus the new therapy. Trials are reviewed by ethics committees called Institutional Review Boards, and participation is always voluntary.
Asking your lymphoma specialist about trials may give you access to promising therapies. Even if a trial is not a match today, others may fit later. Understanding trial phases and the study question can help you decide if a trial meets your goals. Continue reading here.
Coping with life after lymphoma: Mind-body tips for survivorship
When lymphoma treatment ends, you may feel many different emotions, including some you don’t expect. It’s common to experience new emotional and physical struggles during a transition period of recovery.
Mind-body practices can lower stress and support recovery. Try short “minis” during the day, such as taking three deep breaths, a brief stretch, or a 30-second guided visualization. To manage fatigue, tracking your energy levels may help by choosing lighter tasks on low-energy days and bigger tasks when energy is higher. Learn more here.
Subscribe to the lymphoma newsletter
If you’d like to stay up-to-date with HealthTree News for lymphoma, click the button below to subscribe to our newsletter!
Sources:
On September 15, 2025, World Lymphoma Awareness Day brings attention to the needs of people living with lymphoma as part of September’s Blood Cancer Awareness Month.
Below, discover a roundup of recent lymphoma topics shared on HealthTree News, including managing lymphedema after radiation, updates that may improve access to CAR T-cell therapy, how clinical trials work, and coping with life after treatment.
What is lymphoma?
Lymphoma is a blood cancer that affects a type of white blood cell called lymphocytes. Lymphocytes help fight infection and are located in the lymphatic system, which contains lymph nodes, the spleen, thymus, tonsils, and bone marrow.
There are two main types of lymphoma: non-Hodgkin and Hodgkin. Within these two groups, there are more than 90 different subtypes. A lymphoma specialist can identify the exact subtype and recommend the most appropriate treatment plan for you or your loved one.
Non-Hodgkin lymphoma can happen at any age. Although the majority of people affected are age 65 or older, it is one of the more common cancers among youth. Hodgkin lymphoma is more likely to affect people ages 20 to 39 or those 65 and older. According to the American Cancer Society, about 89,070 people in the United States will be diagnosed with lymphoma in 2025 (80,350 non-Hodgkin and 8,720 Hodgkin).
HealthTree News regularly shares updates about lymphoma to help people and their care partners stay informed. Here are some of the highlights you may have missed:
Lymphedema after radiation for lymphoma: Signs, risk factors, and treatment
Lymphedema can develop after radiation therapy for lymphoma. This condition happens when lymph fluid builds up under the skin, causing swelling in areas such as the arms or legs. It can occur shortly after treatment or even years later, which makes long-term awareness important. Recognizing early signs like heaviness, tightness, or skin changes and communicating them to your doctor may help prevent it from getting worse.
Managing lymphedema includes complete decongestive therapy with a certified lymphedema therapist. They can help you with gentle manual lymphatic drainage, compression wraps or garments, specific exercises, and careful skin care. Continue reading here.
FDA determines CAR-T can be safely given without risk evaluation and mitigation strategies (REMS)
On June 27, 2025, the U.S. Food and Drug Administration (FDA) removed special safety requirements, called Risk Evaluation and Mitigation Strategies (REMS), from currently approved autologous CAR T-cell therapies. For people with lymphoma, this change applies to the CAR-T products axi-cel (Yescarta), brexu-cel (Tecartus), liso-cel (Breyanzi), and tisa-cel (Kymriah).
This means hospitals and treatment centers no longer need special certification or to keep the medicine tocilizumab immediately available on-site. Some monitoring requirements were also reduced. For example, patients now only need to stay near a treatment center and avoid driving for two weeks after infusion, instead of longer periods. These updates may make CAR-T easier to access. Learn more about this topic here.
What people with lymphoma should know about clinical trials
Clinical trials are research studies that test new therapies and compare them with current standard care. Most lymphoma trials do not use placebos alone. Patients usually receive either the standard treatment or the standard treatment plus the new therapy. Trials are reviewed by ethics committees called Institutional Review Boards, and participation is always voluntary.
Asking your lymphoma specialist about trials may give you access to promising therapies. Even if a trial is not a match today, others may fit later. Understanding trial phases and the study question can help you decide if a trial meets your goals. Continue reading here.
Coping with life after lymphoma: Mind-body tips for survivorship
When lymphoma treatment ends, you may feel many different emotions, including some you don’t expect. It’s common to experience new emotional and physical struggles during a transition period of recovery.
Mind-body practices can lower stress and support recovery. Try short “minis” during the day, such as taking three deep breaths, a brief stretch, or a 30-second guided visualization. To manage fatigue, tracking your energy levels may help by choosing lighter tasks on low-energy days and bigger tasks when energy is higher. Learn more here.
Subscribe to the lymphoma newsletter
If you’d like to stay up-to-date with HealthTree News for lymphoma, click the button below to subscribe to our newsletter!
Sources:
about the author
Megan Heaps
Megan joined HealthTree in 2022. She enjoys helping patients and their care partners understand the various aspects of the cancer. This understanding enables them to better advocate for themselves and improve their treatment outcomes.
More on Navigating Your Health
Get the Latest Mucosa-Associated Lymphoid Tissue Lymphoma Updates, Delivered to You.
By subscribing to the HealthTree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.